More about the "ARB MI paradox".
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17699164.
- Also identified by PMC identifier 1955006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
"Logic dictates that angiotensin converting enzyme inhibitors should remain the preferred drug across the entire spectrum of cardiometabolic disease"
Medical subject headings
- Angiotensin II Type 1 Receptor Blockers
- Antihypertensive Agents
- Myocardial Infarction